Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-07-076458
Filing Date
2007-12-19
Accepted
2007-12-19 11:59:20
Documents
1
Period of Report
2007-12-17

Document Format Files

Seq Description Document Type Size
1 12/17/07 INITIAL GRANT rrd183345.html 4  
1 12/17/07 INITIAL GRANT rrd183345.xml 4 3713
  Complete submission text file 0001181431-07-076458.txt   5646
Mailing Address 61 MOULTON ST CAMBRIDGE MA 02138
Business Address 61 MOULTON ST CAMBRIDGE MA 02138 6178760086
CURIS INC (Issuer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address CALLISTO PHARMACEUTICALS, INC. 420 LEXINGTON AVE, SUITE 1609 NEW YORK NY 10170
Business Address C/O ALFACELL CORP 225 BELLEVILLE AVE BLOOMFIELD NJ 07003 2122970010
CARTER STEPHEN (Reporting) CIK: 0001135217 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30347 | Film No.: 071315536